Alison Evans

1.4k total citations
49 papers, 943 citations indexed

About

Alison Evans is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Alison Evans has authored 49 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Alison Evans's work include Growth Hormone and Insulin-like Growth Factors (8 papers), Diabetes Treatment and Management (7 papers) and Diet and metabolism studies (4 papers). Alison Evans is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), Diabetes Treatment and Management (7 papers) and Diet and metabolism studies (4 papers). Alison Evans collaborates with scholars based in United Kingdom, Australia and United States. Alison Evans's co-authors include Andrew J. Krentz, Andrew Bates, Peter J.H. Jones, R. N. Clayton, Graeme M. Clark, Brianna C. Thompson, Gordon G. Wallace, Stephen O’Leary, Rachael T. Richardson and Simon E. Moulton and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and Journal of Controlled Release.

In The Last Decade

Alison Evans

44 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Evans United Kingdom 17 269 155 150 145 144 49 943
Klaus Fechner Germany 20 145 0.5× 141 0.9× 261 1.7× 130 0.9× 89 0.6× 36 1.2k
Clive R. Hamlin United States 14 107 0.4× 140 0.9× 335 2.2× 23 0.2× 80 0.6× 30 1.0k
Ding Xie United States 18 378 1.4× 169 1.1× 418 2.8× 104 0.7× 210 1.5× 39 1.3k
Song Wen China 20 232 0.9× 122 0.8× 315 2.1× 55 0.4× 214 1.5× 62 1.4k
Dong‐Hoon Kim South Korea 20 77 0.3× 180 1.2× 294 2.0× 154 1.1× 194 1.3× 108 1.4k
Mohammed Ahmed Saudi Arabia 20 487 1.8× 238 1.5× 225 1.5× 19 0.1× 53 0.4× 69 1.2k
Akira Nakatani Japan 18 349 1.3× 75 0.5× 808 5.4× 39 0.3× 42 0.3× 45 1.5k
Matthew O. Barrett United States 18 29 0.1× 132 0.9× 394 2.6× 70 0.5× 48 0.3× 38 932
Takehito TAGUCHI Japan 21 126 0.5× 331 2.1× 391 2.6× 134 0.9× 52 0.4× 76 1.4k
Dumitru Brănișteanu Romania 17 162 0.6× 92 0.6× 225 1.5× 127 0.9× 13 0.1× 56 1.0k

Countries citing papers authored by Alison Evans

Since Specialization
Citations

This map shows the geographic impact of Alison Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Evans more than expected).

Fields of papers citing papers by Alison Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Evans. The network helps show where Alison Evans may publish in the future.

Co-authorship network of co-authors of Alison Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Evans. A scholar is included among the top collaborators of Alison Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Evans. Alison Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adamson, Karen, Alex Bickerton, Alison Evans, et al.. (2023). factors predicting glucose and weight response to injectable semaglutide (Ozempic): real-world data from the Association of British Clinical Diabetologists’ audit programme. British Journal of Diabetes. 23(2). 94–100. 3 indexed citations
3.
Moon, Richard, et al.. (2020). Slow-Growing Pituitary Metastasis from Renal Cell Carcinoma: Literature Review. World Neurosurgery. 145. 416–425. 5 indexed citations
4.
Hsing, Pen‐Yuan, Santiago Herrera, Catriona Munro, et al.. (2012). Exploration and Discovery of Hydrocarbon Seeps, Coral Ecosystems, and Shipwrecks in the Deep Gulf of Mexico. University of New Hampshire Scholars Repository (University of New Hampshire at Manchester). 2012. 1 indexed citations
5.
Wang, Xiaofang, Qingju Wang, Ali Ghasemzadeh, et al.. (2009). Differences in Macro- and Microarchitecture of the Appendicular Skeleton in Young Chinese and White Women. Journal of Bone and Mineral Research. 24(12). 1946–1952. 52 indexed citations
6.
Thompson, Brianna C., Rachael T. Richardson, Simon E. Moulton, et al.. (2009). Conducting polymers, dual neurotrophins and pulsed electrical stimulation — Dramatic effects on neurite outgrowth. Journal of Controlled Release. 141(2). 161–167. 140 indexed citations
7.
Evans, Alison, Brianna C. Thompson, Gordon G. Wallace, et al.. (2008). Promoting neurite outgrowth from spiral ganglion neuron explants using polypyrrole/BDNF‐coated electrodes. Journal of Biomedical Materials Research Part A. 91A(1). 241–250. 91 indexed citations
8.
Iuliano-Burns, Sandra, Xiaofang Wang, Alison Evans, JP Bonjour, & Ego Seeman. (2006). Skeletal benefits from calcium supplementation are limited in children with calcium intakes near 800 mg daily. Osteoporosis International. 17(12). 1794–1800. 11 indexed citations
9.
Wilkes, Scott, Alison Evans, Martin Gibson, et al.. (2005). Heart disease. Family Practice. 22(suppl_1). 88–88.
10.
Wang, Xiaofang, et al.. (2005). Structural and biomechanical basis of racial and sex differences in vertebral fragility in Chinese and Caucasians. Bone. 36(6). 987–998. 41 indexed citations
11.
Evans, Alison & Andrew J. Krentz. (2001). Insulin resistance and β‐cell dysfunction as therapeutic targets in type 2 diabetes. Diabetes Obesity and Metabolism. 3(4). 219–229. 9 indexed citations
12.
Abbasakoor, F, Alison Evans, & B. M. Stephenson. (2000). Obstructed defecation after undiverted ileoanal pouch reconstruction for ulcerative colitis: Pharmacologic approach. Diseases of the Colon & Rectum. 43(11). 1599–1600.
13.
Evans, Alison & Andrew J. Krentz. (1999). Benefits and Risks of Transfer from Oral Agents to Insulin in Type 2 Diabetes Mellitus. Drug Safety. 21(1). 7–22. 21 indexed citations
14.
Evans, Alison & Andrew J. Krentz. (1999). Recent Developments and Emerging Therapies for Type 2 Diabetes Mellitus. Drugs in R&D. 2(2). 75–94. 23 indexed citations
15.
Krentz, Andrew J. & Alison Evans. (1998). Selective imidazoline receptor agonists for metabolic syndrome. The Lancet. 351(9097). 152–153. 21 indexed citations
16.
Walsh, John, et al.. (1997). Effects of amlodipine in patients with chronic heart failure. American Heart Journal. 134(5). 872–878. 7 indexed citations
17.
Evans, Alison, et al.. (1996). The reproducibility of urinary growth hormone measurement in children undergoing adenotonsillectomy: a pilot study. Clinical Otolaryngology. 21(1). 54–58. 3 indexed citations
18.
Bates, Andrew, Alison Evans, Peter J.H. Jones, & R. N. Clayton. (1995). Assessment of GH status in acromegaly using serum growth hormone, serum insulin‐like growth factor‐I and urinary growth hormone excretion. Clinical Endocrinology. 42(4). 417–423. 68 indexed citations
19.
Evans, Alison & P. Twining. (1991). Case report: In utero diagnosis of a vein of Galen aneurysm using colour flow Doppler. Clinical Radiology. 44(4). 281–282. 8 indexed citations
20.
Evans, Alison, Debbie Willis, & P J Wood. (1991). The assay of urinary growth hormone in normal and acromegalic adults. Clinical Endocrinology. 35(5). 413–418. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026